News About: Pharm. Industry
Roche Korea under penalty on charge of poor manufacturing record-keeping.
It is very likely that Roche Korea get penalized on charge of their negligence in keeping the drug manufacturing control records.
The Gyeongin KFDA (GKFDA) recently replied with the above possibility to the inquir...
UCB Korea's Xyzal highly effective for rhinitis.
UCB Korea said that in the study for 177 children of 6 to 12 years old for 6 weeks treatment with placebo, Xyzal (cetirizine plus pseudoephedrine) a one-a-day dose anti-histaminics, showed a good efficacy against the ...
Sanofi on free osteoporosis tests for mother and daughter.
Sanofi-Synthelabo in association with Shinchon Severance hospital took a special event of "Free osteoporosis test for mother and daughter" on May 10 in celebrating "the month of sweet home" providing a free bone densi...
Drug Industry focused on high profits and rapid growth.
According to a financial analysis for the listed drug makers having a fiscal year ended at Dec. 31, the business performance during the first quarter of this year showed a remarkable growth in its sales and profits.
...
Dongwha to hold 2005 national sales driving meeting.
Dongwha took a sales meeting of "2005 Sales Driving Movement" at Lotte Training Center from May 6 to 7 for the purpose of implementing the 77th management objects "A strong enterprise through reinforced competitivenes...
Whanin to celebrate launching of Arend 70mg tablet.
Whanin took a national sales meeting for the newly launching event of Arend 70mg tablet at Hae beach resort in Jeju island from May 3 to 4 including other programs such as Halla mountain climbing to encourage the sale...
Daewoong to put full efforts on Easyef for middle Asian markets
Daewoong took a symposium on Easyef (EGF) in Amman, Jordan on May 5 for the purpose of launching Easyef, the world first drug for a wound healing.
Easyef was the first bio tech drug in Korea for the treatment of w...
Kuhnil to enter the major anti-cancer markets.
Kuhnil pharmaceutical company (president: Kim Myeong-joong) made an exclusive distributorship agreement with Biopro Inc. on May 2 for the exclusive distribution of Gliadelwafer, a brain cancer drug.
Gliadelwafer w...
Dongsung on phase III studies for a nasal spray type of insulin
Dongsung agreed with Bentley pharmaceuticals of America for a joint phase III clinical study of the nasal spray type of insulin and a signing ceremony at the dynasty hall of Shilla hotel (2nd fl.) on May 10 (Tuesday) ...
Drug research centers in countryside relocating to Seoul
Most of the pharmaceutical research centers are located in the country side near their plants, but Hyundai and Bukwang recently relocated their research centers to the digital industry park in Seoul (former Guro indus...
